Yifan Zhao - The First Central Clinical College, Tianjin Medical University

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 11 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

A CAR-T Response Prediction Model for R/r B-NHL Patients Based on a T-cell Subset Nomogram

Xiaomei Zhang,Rui Sun,Meng Zhang,Yifan Zhao,Xinping Cao,Ruiting Guo,Yi Zhang,Xingzhong Liu,Cuicui Lyu,Mingfeng Zhao

Cancer Immunology Immunotherapyno. 2 (2024)

引用0浏览0WOS引用

Infectious Complications Distribution Following CLL1 CAR-T Cell Therapy for Acute Myeloid Leukemia

Jianmei Xu, Huan Zhang,Yifan Zhao, Xiaomei Zhang,Shujing Guo, Xiaoxue Shi,Xia Xiao,Hairong Lv, Yu Zhang,Xiaoyuan He,Mingfeng Zhao

crossref（2024）

引用0浏览0引用

Efficacy and Safety of CAR-T Therapy Targeting CLL1 in Patients with Extramedullary Diseases of Acute Myeloid Leukemia

Yifan Zhao,Xue Bai,Shujing Guo, Xiaomei Zhang,Jile Liu, Mohan Zhao, Tianle Xie, Haotian Meng, Yu Zhang,Xiaoyuan He,Mingfeng Zhao

Journal of Translational Medicineno. 1 (2024): 1-12

引用0浏览0WOS引用

Modified Cll1-Cd15/Cd16 Inhibitory Car-T Cells for Mitigating Granulocytopenia Toxicities in the Treatment of Acute Myeloid Leukemia

Rui Zhang,YiFan Zhao,Xiao Chai, Yingshuai Wang, Mohan Zhao,Shujing Guo,Yu Zhang,Mingfeng Zhao

crossref（2024）

引用0浏览0引用

Multi-centers Experience Using Therapeutic Plasma Exchange for Corticosteroid/tocilizumab-Refractory Cytokine Release Syndrome Following CAR-T Therapy

Yedi Pu,Yifan Zhao,Yuekun Qi,Yang Liu,Meng Zhang,Xia Xiao,Hairong Lyu,Juanxia Meng,Haibo Zhu,Kailin Xu,Weidong Han,Mingfeng Zhao

INTERNATIONAL IMMUNOPHARMACOLOGY (2024)

引用0浏览0WOS引用

Case Report: Successful Combination of CLL1 CAR-T Therapy and Hematopoietic Stem Cell Transplantation in a 73-Year-old Patient Diagnosed with Refractory Acute Myeloid Leukemia

Yifan Zhao,Hao Wang, Yu Zhang,Yi Zhang, Xiaomei Zhang, Mohan Zhao,Jile Liu,Shujing Guo,Mingfeng Zhao

FRONTIERS IN IMMUNOLOGY（2024）

引用0浏览0WOS引用

Modified EASIX Scores Predict Severe CRS/ICANS in Patients with Acute Myeloid Leukemia Following CLL1 CAR-T Cell Therapy

Yifan Zhao,Xiaomei Zhang,Meng Zhang,Ruiting Guo,Yi Zhang,Yedi Pu,Haibo Zhu,Pengjiang Liu,Yu Zhang,Xiaoyuan He,Cuicui Lyu,Hairong Lyu,Xia Xiao,Mingfeng Zhao

ANNALS OF HEMATOLOGY（2024）

引用0浏览0WOS引用

Targeted CD7 CAR T-cells for Treatment of T-Lymphocyte Leukemia and Lymphoma and Acute Myeloid Leukemia: Recent Advances

Jile Liu,Yi Zhang,Ruiting Guo,Yifan Zhao,Rui Sun,Shujing Guo,Wenyi Lu,Mingfeng Zhao

Frontiers in immunology (2023): 1170968-1170968

引用1浏览0WOS引用

A Phase I Clinical Trial of CLL-1 CAR-T Cells for the Treatment of Relapsed/Refractory Acute Myeloid Leukemia in Adults

Xiaomei Zhang,Hairong Lv,Xia Xiao,Xue Bai,Pengjiang Liu,Yedi Pu,Juanxia Meng,Haibo Zhu, Zhao Wang, Huan Zhang, Yu Zhang,Cuicui Lv, Li Ma,Ting Yuan,Meng Zhang,Rui Sun,Yifan Zhao,Xinping Cao,Ruiting Guo,Yi Zhang, Shujing Guo, Jile Liu,Mingfeng Zhao

Bloodno. Supplement 1 (2023): 2106-2106

引用0浏览0引用

Role of Chemokines in T-cell Acute Lymphoblastic Leukemia: from Pathogenesis to Therapeutic Options

Yifan Zhao,Ruiting Guo,Xinping Cao,Yi Zhang,Rui Sun,Wenyi Lu,Mingfeng Zhao

International immunopharmacology (2023): 110396-110396

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn